MedPath

The effect of combination therapy with oral fluconazole and topical cryotherapy on cutaneous leishmaniasis

Not Applicable
Conditions
Cutaneous Leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT2014112320052N1
Lead Sponsor
Vice Chancellor for research of Fasa University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

New case of smear positive cutaneous leishmaniasis; Negative past history of leishmaniais; Weight above 10 kilogram; No treatment for leishmaniasis during the previous 3 months; Disease duration of less than 3 months.
Exclusion criteria: Pregnancy and lactation; Skin lesions located on face and ear; More than 10 skin lesions; Present or past history of renal or cardiac diseases; Lupoid or sporotrichoid leishmaniasis; Clients with Immunedeficiency, HIV or Diabetes

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recovery rate. Timepoint: 6 weeks (at the end of drug therapy) and 10 weeks after the start of trial. Method of measurement: Degree of induration, Smear positivity, Ulcer area.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath